V. Abkevich, K. Timms, B. Hennessy, J. Potter, M. Carey et al., Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer, British Journal of Cancer, vol.474, issue.10, pp.1776-1782, 2012.
DOI : 10.1016/j.cancergencyto.2004.12.017

A. Acedo, C. Hernández-moro, Á. Curiel-garcía, B. Díez-gómez, and E. Velasco, DNA Variants by Splicing Assays in a Large Minigene with 9 Exons, Human Mutation, vol.378, issue.2, pp.210-221, 2015.
DOI : 10.1038/378789a0

S. Anderson, R. Coli, I. Daly, E. Kichula, M. Rork et al., Familial Dysautonomia Is Caused by Mutations of the IKAP Gene, The American Journal of Human Genetics, vol.68, issue.3, pp.753-758, 2001.
DOI : 10.1086/318808

C. Andreutti-zaugg, R. Scott, and R. Iggo, Inhibition of nonsense-mediated messenger RNA decay in clinical samples facilitates detection of human MSH2 mutations with an in vivo fusion protein assay and conventional techniques, Cancer Res, vol.57, pp.3288-3293, 1997.

G. Ast, How did alternative splicing evolve?, Nature Reviews Genetics, vol.13, issue.10, pp.773-782, 2004.
DOI : 10.1016/S0959-437X(96)80053-0

B. Bai, C. Hales, P. Chen, Y. Gozal, E. Dammer et al., U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease, Proceedings of the National Academy of Sciences, vol.56, issue.11, pp.16562-16567, 2013.
DOI : 10.1212/WNL.56.suppl_4.S16

URL : http://www.pnas.org/content/110/41/16562.full.pdf

D. Baralle and M. Baralle, Splicing in action: assessing disease causing sequence changes, Journal of Medical Genetics, vol.42, issue.10, pp.737-748, 2005.
DOI : 10.1136/jmg.2004.029538

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1735933

D. Baralle, A. Lucassen, and E. Buratti, Missed threads. The impact of pre-mRNA splicing defects on clinical practice, EMBO reports, vol.3, issue.8, pp.810-816, 2009.
DOI : 10.1371/journal.pgen.0030109

N. Barbosa-morais, M. Irimia, Q. Pan, H. Xiong, S. Gueroussov et al., The Evolutionary Landscape of Alternative Splicing in Vertebrate Species, Science, vol.20, issue.13, pp.1587-1593, 2012.
DOI : 10.1093/bioinformatics/bth195

M. Berg, L. Singh, I. Younis, Q. Liu, A. Pinto et al., U1 snRNP Determines mRNA Length and Regulates Isoform Expression, Cell, vol.150, issue.1, pp.53-64, 2012.
DOI : 10.1016/j.cell.2012.05.029

URL : http://doi.org/10.1016/j.cell.2012.05.029

S. Berget, Exon Recognition in Vertebrate Splicing, Journal of Biological Chemistry, vol.14, issue.6, pp.2411-2414, 1995.
DOI : 10.1126/science.8085156

URL : http://www.jbc.org/content/270/6/2411.full.pdf

F. Bernier, O. Caluseriu, S. Ng, J. Schwartzentruber, K. Buckingham et al., Haploinsufficiency of SF3B4, a Component of the Pre-mRNA Spliceosomal Complex, Causes Nager Syndrome, The American Journal of Human Genetics, vol.90, issue.5, pp.925-933, 2012.
DOI : 10.1016/j.ajhg.2012.04.004

C. Béroud, S. Letovsky, C. Braastad, S. Caputo, O. Beaudoux et al., BRCA Share: A Collection of Clinical BRCA Gene Variants, Human Mutation, vol.265, issue.12, pp.1318-1328, 2016.
DOI : 10.1126/science.8091231

F. Binder-foucard, N. Bossard, P. Delafosse, A. Belot, A. Woronoff et al., French network of cancer registries (Francim). 2014. Cancer incidence and mortality in France over the 1980-2012 period: solid tumors, pp.95-108

N. Birkbak, Z. Wang, J. Kim, A. Eklund, Q. Li et al., Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents, Cancer Discovery, vol.2, issue.4, pp.366-75, 2012.
DOI : 10.1158/2159-8290.CD-11-0206

URL : http://cancerdiscovery.aacrjournals.org/content/candisc/2/4/366.full.pdf

E. Birney, S. Kumar, and A. Krainer, Analysis of the RNA-recognition motif and RS and RGG domains: conservation in metazoan pre-mRNA splicing factors, Nucleic Acids Research, vol.21, issue.25, pp.5803-5816, 1993.
DOI : 10.1093/nar/21.25.5803

B. Blencowe, Alternative Splicing: New Insights from Global Analyses, Cell, vol.126, issue.1, pp.37-47, 2006.
DOI : 10.1016/j.cell.2006.06.023

URL : http://doi.org/10.1016/j.cell.2006.06.023

L. Boise, M. González-garcía, C. Postema, L. Ding, T. Lindsten et al., bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell, vol.74, issue.4, pp.597-608, 1993.
DOI : 10.1016/0092-8674(93)90508-N

C. Bonnet, S. Krieger, M. Vezain, A. Rousselin, I. Tournier et al., Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene, Journal of Medical Genetics, vol.45, issue.7, pp.438-446, 2008.
DOI : 10.1136/jmg.2007.056895

P. Bork, N. Blomberg, and M. Nilges, Internal repeats in the BRCA2 protein sequence, Nature Genetics, vol.84, issue.1, pp.22-23, 1996.
DOI : 10.1038/379597a0

P. Bouwman, H. Gulden, . Van-der, I. Heijden, . Van-der et al., A High-Throughput Functional Complementation Assay for Classification of BRCA1 Missense Variants, Cancer Discovery, vol.3, issue.10, pp.1142-1155, 2013.
DOI : 10.1158/2159-8290.CD-13-0094

V. Bubien, F. Bonnet, V. Brouste, S. Hoppe, E. Barouk-simonet et al., hamartoma tumour syndrome, Journal of Medical Genetics, vol.50, issue.4, pp.255-263, 2013.
DOI : 10.1136/jmedgenet-2012-101339

O. Capetillo, L. Cao, X. Xu, and C. Deng, 53BP1 inhibits homologous recombination in Brca1- deficient cells by blocking resection of DNA breaks, Cell, vol.141, pp.243-254, 2010.

C. Burge, R. Padgett, and P. Sharp, Evolutionary Fates and Origins of U12-Type Introns, Molecular Cell, vol.2, issue.6, pp.773-785, 1998.
DOI : 10.1016/S1097-2765(00)80292-0

G. Byrnes, M. Southey, and J. Hopper, Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?, Breast Cancer Research, vol.26, issue.3, p.208, 2008.
DOI : 10.1002/humu.20237

S. Camier and B. Séraphin, Détruisez ce message (ARN) après l'avoir lu ! médecine, sciences, vol.23, pp.850-856, 2007.
DOI : 10.1051/medsci/20072310850

URL : http://www.medecinesciences.org/articles/medsci/pdf/2007/11/medsci20072310p850.pdf

S. Caputo, L. Benboudjema, O. Sinilnikova, E. Rouleau, C. Béroud et al., Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases, Nucleic Acids Research, vol.40, issue.D1, pp.992-1002, 2012.
DOI : 10.1093/nar/gkr1160

I. Carmel, S. Tal, I. Vig, and G. Ast, Comparative analysis detects dependencies among the 5' splice-site positions, RNA, vol.10, issue.5, pp.828-840, 2004.
DOI : 10.1261/rna.5196404

K. Carr, Nobel goes to discoverers of ???split genes???, Nature, vol.365, issue.6447, p.597, 1993.
DOI : 10.1038/365597a0

L. Cartegni, S. Chew, and A. Krainer, LISTENING TO SILENCE AND UNDERSTANDING NONSENSE: EXONIC MUTATIONS THAT AFFECT SPLICING, Nature Reviews Genetics, vol.3, issue.4, pp.285-298, 2002.
DOI : 10.1038/nrg775

L. Cartegni and A. Krainer, Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1, Nature Genetics, vol.30, issue.4, pp.377-384, 2002.
DOI : 10.1038/ng854

L. Castéra, S. Krieger, A. Rousselin, A. Legros, J. Baumann et al., Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes, European Journal of Human Genetics, vol.29, issue.11, pp.1305-1313, 2014.
DOI : 10.1073/pnas.1115052108

S. Chang, K. Biswas, B. Martin, S. Stauffer, and S. Sharan, Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations, Journal of Clinical Investigation, vol.119, issue.10, pp.3160-3171, 2009.
DOI : 10.1172/JCI39836DS1

M. Chapman and I. Verma, Transcriptional activation by BRCA1, Nature, vol.382, issue.6593, pp.678-679, 1996.
DOI : 10.1038/382678a0

C. Savkur, R. Singh, G. Philips, A. Grice, E. Cooper et al., Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing, Mol Cell, vol.10, pp.45-53, 2002.

P. Chen, C. Chen, Y. Chen, X. J. Sharp, Z. Lee et al., The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment, Proceedings of the National Academy of Sciences, vol.127, issue.3, pp.5287-5292, 1998.
DOI : 10.1083/jcb.127.3.609

G. Chenevix-trench, S. Healey, S. Lakhani, P. Waring, M. Cummings et al., DNA Sequence Variants of Unknown Clinical Significance, Cancer Research, vol.66, issue.4, pp.2019-2027, 2006.
DOI : 10.1158/0008-5472.CAN-05-3546

L. Chodosh, Expression of BRCA1 and BRCA2 in normal and neoplastic cells, Journal of Mammary Gland Biology and Neoplasia, vol.3, issue.4, pp.389-402, 1998.
DOI : 10.1023/A:1018784031651

E. Claus, N. Risch, and W. Thompson, Genetic analysis of breast cancer in the cancer and steroid hormone study, Am J Hum Genet, vol.48, pp.232-242, 1991.

E. Coene, M. Hollinshead, A. Waeytens, V. Schelfhout, W. Eechaute et al., Phosphorylated BRCA1 Is Predominantly Located in the Nucleus and Mitochondria, Molecular Biology of the Cell, vol.16, issue.2, pp.997-1010, 2005.
DOI : 10.1091/mbc.E04-10-0895

M. Colombo, M. Blok, P. Whiley, M. Santamariña, S. Gutiérrez-enríquez et al., Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium, Human Molecular Genetics, vol.23, issue.14, pp.3666-3680, 2014.
DOI : 10.1093/hmg/ddu075

D. Cortez, Y. Wang, J. Qin, and S. Elledge, Requirement of ATM-Dependent Phosphorylation of Brca1 in the DNA Damage Response to Double-Strand Breaks, Science, vol.286, issue.5442, pp.1162-1166, 1999.
DOI : 10.1126/science.286.5442.1162

M. Cuajungco, M. Leyne, J. Mull, S. Gill, W. Lu et al., Tissue-Specific Reduction in Splicing Efficiency of IKBKAP Due to the Major Mutation Associated with Familial Dysautonomia, The American Journal of Human Genetics, vol.72, issue.3, pp.749-758, 2003.
DOI : 10.1086/368263

E. Daguenet, G. Dujardin, and J. Valcárcel, The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches, EMBO reports, vol.16, issue.12, pp.1640-1655, 2015.
DOI : 10.15252/embr.201541116

D. Conti, L. Baralle, M. Buratti, and E. , Exon and intron definition in pre-mRNA splicing, Wiley Interdisciplinary Reviews: RNA, vol.27, issue.1, pp.49-60, 2013.
DOI : 10.1002/9783527636778

C. Deng and S. Brodie, Roles of BRCA1 and its interacting proteins, BioEssays, vol.57, issue.8, pp.728-737, 2000.
DOI : 10.1038/bjc.1997.526

F. Desmet, D. Hamroun, M. Lalande, G. Collod-béroud, M. Claustres et al., Human Splicing Finder: an online bioinformatics tool to predict splicing signals, Nucleic Acids Research, vol.37, issue.9, p.67, 2009.
DOI : 10.1093/nar/gkp215

URL : https://hal.archives-ouvertes.fr/inserm-00396239

D. Giacomo, D. Gaildrat, P. Abuli, A. Abdat, J. Frébourg et al., exon??7 Variants Highlights the Predictive Value of Hexamer Scores in Detecting Alterations of Exonic Splicing Regulatory Elements, Human Mutation, vol.11, issue.11, pp.1547-1557, 2013.
DOI : 10.1186/1471-2350-11-80

R. Dietrich, R. Incorvaia, and R. Padgett, Terminal Intron Dinucleotide Sequences Do Not Distinguish between U2- and U12-Dependent Introns, Molecular Cell, vol.1, issue.1, pp.151-160, 1997.
DOI : 10.1016/S1097-2765(00)80016-7

URL : http://doi.org/10.1016/s1097-2765(00)80016-7

G. Dreyfuss, V. Kim, and N. Kataoka, MESSENGER-RNA-BINDING PROTEINS AND THE MESSAGES THEY CARRY, Nature Reviews Molecular Cell Biology, vol.3, issue.3, pp.195-205, 2002.
DOI : 10.1038/nrm760

D. Easton, A. Deffenbaugh, D. Pruss, C. Frye, R. Wenstrup et al., A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer???Predisposition Genes, The American Journal of Human Genetics, vol.81, issue.5, 2007.
DOI : 10.1086/521032

P. Edery, C. Marcaillou, M. Sahbatou, A. Labalme, J. Chastang et al., Association of TALS Developmental Disorder with Defect in Minor Splicing Component U4atac snRNA, Science, vol.5, issue.10, pp.240-243, 2011.
DOI : 10.1371/journal.pone.0013215

URL : https://hal.archives-ouvertes.fr/hal-01017145

F. Eisinger, B. Bressac, D. Castaigne, P. Cottu, J. Lansac et al., Identification et??prise en??charge des??pr??dispositions h??r??ditaires aux??cancers du??sein et??de??l'ovaire (mise ????jour 2004), Pathologie Biologie, vol.54, issue.4, pp.230-250, 2004.
DOI : 10.1016/j.patbio.2006.02.002

W. Elshamy and D. Livingston, Identification of BRCA1-IRIS, a BRCA1 locus product, Nature Cell Biology, vol.4, issue.10, pp.954-967, 2004.
DOI : 10.1007/s004390050686

F. Esashi, N. Christ, J. Gannon, Y. Liu, T. Hunt et al., CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair, Nature, vol.12, issue.7033, pp.598-604, 2005.
DOI : 10.1101/gad.13.20.2633

J. Fackenthal, T. Yoshimatsu, B. Zhang, G. Garibay, . De et al., Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples, J Med Genet, 2016.
DOI : 10.1136/jmedgenet-2015-103570

W. Fairbrother, R. Yeh, P. Sharp, and C. Burge, Predictive Identification of Exonic Splicing Enhancers in Human Genes, Science, vol.297, issue.5583, pp.1007-1013, 2002.
DOI : 10.1126/science.1073774

D. Farrugia, M. Agarwal, V. Pankratz, A. Deffenbaugh, D. Pruss et al., Functional Assays for Classification of BRCA2 Variants of Uncertain Significance, Cancer Research, vol.68, issue.9, pp.3523-3531, 2008.
DOI : 10.1158/0008-5472.CAN-07-1587

M. Fernández-nogales, J. Cabrera, M. Santos-galindo, J. Hoozemans, I. Ferrer et al., Huntington's disease is a four-repeat tauopathy with tau nuclear rods, Nature Medicine, vol.114, issue.8, pp.881-885, 2014.
DOI : 10.1016/S0092-8674(00)80623-6

I. Fokkema, P. Taschner, G. Schaafsma, J. Celli, J. Laros et al., LOVD v.2.0: the next generation in gene variant databases, Human Mutation, vol.29, issue.5, pp.557-563, 2011.
DOI : 10.1002/humu.20654

N. Foray, D. Marot, A. Gabriel, V. Randrianarison, A. Carr et al., A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein, The EMBO Journal, vol.22, issue.11, pp.2860-2871, 2003.
DOI : 10.1093/emboj/cdg274

J. Fortin, A. Moisan, M. Dumont, G. Leblanc, Y. Labrie et al., A new alternative splice variant of BRCA1 containing an additional in-frame exon, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1731, issue.1, pp.57-65, 2005.
DOI : 10.1016/j.bbaexp.2005.08.011

K. Fox-walsh, Y. Dou, B. Lam, S. Hung, P. Baldi et al., The architecture of pre-mRNAs affects mechanisms of splice-site pairing, Proceedings of the National Academy of Sciences, vol.4, issue.5, pp.16176-16181, 2005.
DOI : 10.1016/0168-9525(88)90136-9

A. Frankish, J. Mudge, M. Thomas, and J. Harrow, The importance of identifying alternative splicing in vertebrate genome annotation, Database, vol.2012, issue.0, p.14, 2012.
DOI : 10.1093/database/bas014

T. Frebourg, The Challenge for the Next Generation of Medical Geneticists, Human Mutation, vol.369, issue.8, pp.909-911, 2014.
DOI : 10.1056/NEJMoa1306555

A. Fredericks, K. Cygan, B. Brown, and W. Fairbrother, RNA-Binding Proteins: Splicing Factors and Disease, Biomolecules, vol.23, issue.2, pp.893-909, 2015.
DOI : 10.1038/mt.2013.251

URL : http://doi.org/10.3390/biom5020893

M. Frilander and J. Steitz, Initial recognition of U12-dependent introns requires both U11/5' splice-site and U12/branchpoint interactions, Genes & Development, vol.13, issue.7, pp.851-863, 1999.
DOI : 10.1101/gad.13.7.851

URL : http://genesdev.cshlp.org/content/13/7/851.full.pdf

X. Fu, The superfamily of arginine/serine-rich splicing factors, RNA, vol.1, pp.663-680, 1995.

X. Fu and M. Ares, Context-dependent control of alternative splicing by RNA-binding proteins, Nature Reviews Genetics, vol.486, issue.10, pp.689-701, 2014.
DOI : 10.1128/MCB.00740-13

F. Fuks, J. Milner, and T. Kouzarides, BRCA2 associates with acetyltransferase activity when bound to P/CAF, Oncogene, vol.17, issue.19, pp.2531-2534, 1998.
DOI : 10.1038/sj.onc.1202475

P. Gaildrat, A. Killian, A. Martins, I. Tournier, T. Frébourg et al., Use of Splicing Reporter Minigene Assay to Evaluate the Effect on Splicing of Unclassified Genetic Variants, Methods Mol Biol Clifton NJ, vol.653, pp.249-257, 2010.
DOI : 10.1007/978-1-60761-759-4_15

P. Gaildrat, S. Krieger, D. Giacomo, D. Abdat, J. Révillion et al., exon 7 alter splicing regulation, Journal of Medical Genetics, vol.49, issue.10, pp.609-617, 2012.
DOI : 10.1136/jmedgenet-2012-100965

P. Gaildrat, S. Krieger, J. Théry, A. Killian, A. Rousselin et al., The BRCA1 c.5434C->G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements, Journal of Medical Genetics, vol.47, issue.6, pp.398-403, 2010.
DOI : 10.1136/jmg.2009.074047

URL : https://hal.archives-ouvertes.fr/hal-00557379

V. Gerbino, M. Carrì, M. Cozzolino, and T. Achsel, Mislocalised FUS mutants stall spliceosomal snRNPs in the cytoplasm, Neurobiology of Disease, vol.55, pp.120-128, 2013.
DOI : 10.1016/j.nbd.2013.03.003

F. Giardiello, J. Brensinger, A. Tersmette, S. Goodman, G. Petersen et al., Very high risk of cancer in familial Peutz???Jeghers syndrome, Gastroenterology, vol.119, issue.6, pp.1447-1453, 2000.
DOI : 10.1053/gast.2000.20228

W. Gilbert, Why genes in pieces?, Nature, vol.74, issue.5645, p.501, 1978.
DOI : 10.1016/0092-8674(77)90172-6

D. Goldgar, D. Easton, A. Deffenbaugh, A. Monteiro, S. Tavtigian et al., Integrated Evaluation of DNA Sequence Variants of Unknown Clinical Significance: Application to BRCA1 and BRCA2, The American Journal of Human Genetics, vol.75, issue.4, pp.535-544, 2004.
DOI : 10.1086/424388

L. Golmard, V. Caux-moncoutier, G. Davy, A. Ageeli, E. Poirot et al., Germline mutation in the RAD51B gene confers predisposition to breast cancer, BMC Cancer, vol.44, issue.1, p.484, 2013.
DOI : 10.1038/ng.2224

URL : https://hal.archives-ouvertes.fr/inserm-00878230

C. Gooding, F. Clark, M. Wollerton, S. Grellscheid, H. Groom et al., A class of human exons with predicted distant branch points revealed by analysis of AG dinucleotide exclusion zones, 2006.

A. Goren, O. Ram, M. Amit, H. Keren, G. Lev-maor et al., Comparative Analysis Identifies Exonic Splicing Regulatory Sequences???The Complex Definition of Enhancers and Silencers, Molecular Cell, vol.22, issue.6, pp.769-781, 2006.
DOI : 10.1016/j.molcel.2006.05.008

L. Gowen, B. Johnson, A. Latour, K. Sulik, and B. Koller, Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities, Nature Genetics, vol.4, issue.2, pp.191-194, 1996.
DOI : 10.1038/326292a0

O. Gozani, R. Feld, and R. Reed, Evidence that sequence-independent binding of highly conserved U2 snRNP proteins upstream of the branch site is required for assembly of spliceosomal complex A., Genes & Development, vol.10, issue.2, pp.233-243, 1996.
DOI : 10.1101/gad.10.2.233

O. Gozani, J. Potashkin, and R. Reed, A Potential Role for U2AF-SAP 155 Interactions in Recruiting U2 snRNP to the Branch Site, Molecular and Cellular Biology, vol.18, issue.8, pp.4752-4760, 1998.
DOI : 10.1128/MCB.18.8.4752

B. Graveley, Alternative splicing: increasing diversity in the proteomic world, Trends in Genetics, vol.17, issue.2, pp.100-107, 2001.
DOI : 10.1016/S0168-9525(00)02176-4

R. Greenberg, Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network, Chromosoma, vol.100, issue.24, pp.305-317, 2008.
DOI : 10.1093/jnci/94.13.990

E. Groen, K. Fumoto, A. Blokhuis, J. Engelen-lee, Y. Zhou et al., ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN, Human Molecular Genetics, vol.22, issue.18, pp.3690-3704, 2013.
DOI : 10.1093/hmg/ddt222

A. Grover, H. Houlden, M. Baker, J. Adamson, J. Lewis et al., Associated with the Inherited Dementia FTDP-17 Affect a Stem-Loop Structure That Regulates Alternative Splicing of Exon 10, Journal of Biological Chemistry, vol.13, issue.21, pp.15134-15143, 1999.
DOI : 10.1093/nar/9.1.133

J. Gui, W. Lane, and X. Fu, A serine kinase regulates intracellular localization of splicing factors in the cell cycle, Nature, vol.369, issue.6482, pp.678-682, 1994.
DOI : 10.1038/369678a0

L. Guidugli, V. Pankratz, N. Singh, J. Thompson, C. Erding et al., A Classification Model for BRCA2 DNA Binding Domain Missense Variants Based on Homology-Directed Repair Activity, Cancer Research, vol.73, issue.1, pp.265-275, 2013.
DOI : 10.1158/0008-5472.CAN-12-2081

URL : http://cancerres.aacrjournals.org/content/canres/73/1/265.full.pdf

R. Hakem, J. Pompa, . De-la, C. Sirard, R. Mo et al., The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse, Cell, vol.85, issue.7, pp.1009-1023, 1996.
DOI : 10.1016/S0092-8674(00)81302-1

H. He, S. Liyanarachchi, K. Akagi, R. Nagy, J. Li et al., Mutations in U4atac snRNA, a Component of the Minor Spliceosome, in the Developmental Disorder MOPD I, Science, vol.47, issue.12, pp.238-240, 2011.
DOI : 10.1136/jmg.2009.067298

E. Heinzen, D. Ge, K. Cronin, J. Maia, K. Shianna et al., Tissue-Specific Genetic Control of Splicing: Implications for the Study of Complex Traits, PLoS Biology, vol.357, issue.12, p.1000001, 2008.
DOI : 10.1371/journal.pbio.1000001.st005

F. Hilbers, J. Wijnen, N. Hoogerbrugge, J. Oosterwijk, M. Collee et al., Rare variants in XRCC2 as breast cancer susceptibility alleles: Table??1, Journal of Medical Genetics, vol.49, issue.10, pp.618-620, 2012.
DOI : 10.1136/jmedgenet-2012-101191

S. Ho, H. Hunt, R. Horton, J. Pullen, and L. Pease, Site-directed mutagenesis by overlap extension using the polymerase chain reaction, Gene, vol.77, issue.1, pp.51-59, 1989.
DOI : 10.1016/0378-1119(89)90358-2

C. Houdayer, V. Caux-moncoutier, S. Krieger, M. Barrois, F. Bonnet et al., Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants, Human Mutation, vol.39, issue.8, pp.1228-1238, 2012.
DOI : 10.1073/pnas.0801692105

C. Houdayer, C. Dehainault, C. Mattler, D. Michaux, V. Caux-moncoutier et al., Evaluation of in silico splice tools for decision-making in molecular diagnosis, Human Mutation, vol.24, issue.7, pp.975-982, 2008.
DOI : 10.1002/humu.20765

J. Howard and J. Sanford, The RNAissance family: SR proteins as multifaceted regulators of gene expression, Wiley Interdisciplinary Reviews: RNA, vol.15, issue.2, pp.93-110, 2015.
DOI : 10.1186/gb-2014-15-1-r15

L. Hsu and R. White, BRCA1 is associated with the centrosome during mitosis, Proceedings of the National Academy of Sciences, vol.57, issue.7, pp.12983-12988, 1998.
DOI : 10.1038/ng0495-444

URL : http://www.pnas.org/content/95/22/12983.full.pdf

L. Hughes-davies, D. Huntsman, M. Ruas, F. Fuks, J. Bye et al., EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian Cancer, Cell, vol.115, issue.5, pp.523-535, 2003.
DOI : 10.1016/S0092-8674(03)00930-9

URL : http://doi.org/10.1016/s0092-8674(03)00930-9

M. Hutton, C. Lendon, P. Rizzu, M. Baker, S. Froelich et al., Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17, Nature, vol.393, issue.6686, pp.702-705, 1998.
DOI : 10.1038/31508

E. Ibrahim, M. Hims, N. Shomron, C. Burge, S. Slaugenhaupt et al., exon 20 leads to aberrant splicing in familial dysautonomia, Human Mutation, vol.10, issue.1, pp.41-53, 2007.
DOI : 10.1128/MCB.13.8.4939

URL : https://hal.archives-ouvertes.fr/hal-00320236

T. Ishihara, Y. Ariizumi, A. Shiga, T. Kato, C. Tan et al., Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis, Human Molecular Genetics, vol.22, issue.20, pp.4136-4147, 2013.
DOI : 10.1093/hmg/ddt262

J. Izquierdo, N. Majós, S. Bonnal, C. Martínez, R. Castelo et al., Regulation of Fas Alternative Splicing by Antagonistic Effects of TIA-1 and PTB on Exon Definition, Molecular Cell, vol.19, issue.4, pp.475-484, 2005.
DOI : 10.1016/j.molcel.2005.06.015

C. Jensen, B. Oldfield, and J. Rubio, genetic variation and disease: Figure 1, Biochemical Society Transactions, vol.37, issue.6, pp.1311-1315, 2009.
DOI : 10.1042/BST0371311

Z. Kais, N. Chiba, C. Ishioka, and J. Parvin, Functional differences among BRCA1 missense mutations in the control of centrosome duplication, Oncogene, vol.3, issue.6, pp.799-804, 2012.
DOI : 10.1016/S1097-2765(00)80466-9

A. Kalsotra and T. Cooper, Functional consequences of developmentally regulated alternative splicing, Nature Reviews Genetics, vol.234, issue.10, pp.715-729, 2011.
DOI : 10.1002/dvdy.20489

T. Kashima and J. Manley, A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy, Nature Genetics, vol.34, issue.4, pp.460-463, 2003.
DOI : 10.1038/ng1207

K. Kast, K. Rhiem, B. Wappenschmidt, E. Hahnen, J. Hauke et al., germline mutations in 21???401 families with breast and ovarian cancer, Journal of Medical Genetics, vol.36, issue.(Suppl 7), pp.465-471, 2016.
DOI : 10.1016/j.humpath.2005.06.006

N. Kfir, G. Lev-maor, O. Glaich, A. Alajem, A. Datta et al., SF3B1 Association with Chromatin Determines Splicing Outcomes, Cell Reports, vol.11, issue.4, pp.618-629, 2015.
DOI : 10.1016/j.celrep.2015.03.048

URL : http://doi.org/10.1016/j.celrep.2015.03.048

E. Kim, A. Magen, and G. Ast, Different levels of alternative splicing among eukaryotes, Nucleic Acids Research, vol.35, issue.1, pp.125-131, 2007.
DOI : 10.1093/nar/gkl924

URL : http://doi.org/10.1093/nar/gkl924

H. Kobayashi, S. Ohno, Y. Sasaki, and M. Matsuura, Hereditary breast and ovarian cancer susceptibility genes (Review), Oncology Reports, vol.30, pp.1019-1029, 2013.
DOI : 10.3892/or.2013.2541

M. Konarska, J. Vilardell, and C. Query, Repositioning of the Reaction Intermediate within the Catalytic Center of the Spliceosome, Molecular Cell, vol.21, issue.4, pp.543-553, 2006.
DOI : 10.1016/j.molcel.2006.01.017

M. Krawczak, N. Thomas, B. Hundrieser, M. Mort, M. Wittig et al., Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicing, Human Mutation, vol.15, issue.2, pp.150-158, 2007.
DOI : 10.1002/humu.20400

A. Krecic and M. Swanson, hnRNP complexes: composition, structure, and function, Current Opinion in Cell Biology, vol.11, issue.3, pp.363-371, 1999.
DOI : 10.1016/S0955-0674(99)80051-9

W. Kugler, J. Enssle, M. Hentze, and A. Kulozik, Nuclear degradation of nonsense mutated ??-globin mRNA: a post-transcriptional mechanism to protect heterozygotes from severe clinical manifestations of ??-thalassemia?, Nucleic Acids Research, vol.23, issue.3, pp.413-418, 1995.
DOI : 10.1093/nar/23.3.413

T. Kurosaki and L. Maquat, Nonsense-mediated mRNA decay in humans at a glance, Journal of Cell Science, vol.129, issue.3, pp.461-467, 2016.
DOI : 10.1242/jcs.181008

N. Kuyumcu-martinez, G. Wang, and T. Cooper, Increased Steady-State Levels of CUGBP1 in Myotonic Dystrophy 1 Are Due to PKC-Mediated Hyperphosphorylation, Molecular Cell, vol.28, issue.1, pp.68-78, 2007.
DOI : 10.1016/j.molcel.2007.07.027

S. Kuznetsov, P. Liu, and S. Sharan, Mouse embryonic stem cell???based functional assay to evaluate mutations in BRCA2, Nature Medicine, vol.176, issue.8, pp.875-881, 2008.
DOI : 10.1016/j.mrfmmm.2006.07.003

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2640324

T. Kwiatkowski, D. Bosco, A. Leclerc, E. Tamrazian, C. Vanderburg et al., Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis, Science, vol.18, issue.10, pp.1205-1208, 2009.
DOI : 10.1074/jbc.M705306200

E. Lander, L. Linton, B. Birren, C. Nusbaum, M. Zody et al., Initial sequencing and analysis of the human genome, Nature, vol.6, issue.6822, pp.860-921, 2001.
DOI : 10.1089/cmb.1999.6.91

M. Landrum, J. Lee, G. Riley, W. Jang, W. Rubinstein et al., ClinVar: public archive of relationships among sequence variation and human phenotype, Nucleic Acids Research, vol.42, issue.D1, pp.980-985, 2014.
DOI : 10.1093/nar/gkt1113

J. Lee and T. Paull, ATM Activation by DNA Double-Strand Breaks Through the Mre11-Rad50-Nbs1 Complex, Science, vol.308, issue.5721, pp.551-554, 2005.
DOI : 10.1126/science.1108297

Y. Lee and D. Rio, Mechanisms and Regulation of Alternative Pre-mRNA Splicing, Annual Review of Biochemistry, vol.84, issue.1, pp.291-323, 2015.
DOI : 10.1146/annurev-biochem-060614-034316

S. Lefebvre, L. Bürglen, S. Reboullet, O. Clermont, P. Burlet et al., Identification and characterization of a spinal muscular atrophy-determining gene, Cell, vol.80, issue.1, pp.155-165, 1995.
DOI : 10.1016/0092-8674(95)90460-3

M. Lek, K. Karczewski, E. Minikel, K. Samocha, E. Banks et al., Analysis of protein-coding genetic variation in 60,706 humans, Nature, vol.32, issue.7616, pp.285-291, 2016.
DOI : 10.1038/nbt.2835

M. Lewandowska, The missing puzzle piece: splicing mutations, Int J Clin Exp Pathol, vol.6, pp.2675-2682, 2013.

X. Lin, J. Miller, A. Mankodi, R. Kanadia, Y. Yuan et al., Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy, Human Molecular Genetics, vol.15, issue.13, pp.2087-2097, 2006.
DOI : 10.1093/hmg/ddl132

N. Lindor, L. Guidugli, X. Wang, M. Vallée, A. Monteiro et al., A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS), Human Mutation, vol.32, issue.1, pp.8-21, 2012.
DOI : 10.1002/humu.21495

M. Lines, L. Huang, J. Schwartzentruber, S. Douglas, D. Lynch et al., Haploinsufficiency of a Spliceosomal GTPase Encoded by EFTUD2 Causes Mandibulofacial Dysostosis with Microcephaly, The American Journal of Human Genetics, vol.90, issue.2, pp.369-377, 2012.
DOI : 10.1016/j.ajhg.2011.12.023

W. Lingle, W. Lutz, J. Ingle, N. Maihle, and J. Salisbury, Centrosome hypertrophy in human breast tumors: Implications for genomic stability and cell polarity, Proceedings of the National Academy of Sciences, vol.84, issue.3, pp.2950-2955, 1998.
DOI : 10.1016/0277-5379(87)90071-X

C. Liquori, K. Ricker, M. Moseley, J. Jacobsen, W. Kress et al., Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9, Science, vol.293, issue.5531, pp.864-867, 2001.
DOI : 10.1126/science.1062125

C. Lorson, E. Hahnen, E. Androphy, and B. Wirth, A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy, Proceedings of the National Academy of Sciences, vol.64, issue.5, pp.6307-6311, 1999.
DOI : 10.1086/302369

C. Loveday, C. Turnbull, E. Ruark, R. Xicola, E. Ramsay et al., Germline RAD51C mutations confer susceptibility to ovarian cancer, Nature Genetics, vol.38, issue.5, pp.475-476, 2012.
DOI : 10.1038/ng1902

H. Lynch, H. Guirgis, A. S. Brennan, M. Lynch, J. Kraft et al., FAMILIAL ASSOCIATION OF CARCINOMA OF THE BREAST AND OVARY, Obstetrical & Gynecological Survey, vol.30, issue.1, pp.717-724, 1974.
DOI : 10.1097/00006254-197501000-00022

H. Lynch, R. Harris, H. Guirgis, P. Lynch, K. Maloney et al., Early age of onset and familial breast cancer, Lancet Lond Engl, vol.2, pp.626-627, 1976.
DOI : 10.1016/s0140-6736(76)90688-7

H. Lynch and A. Krush, CARCINOMA OF THE BREAST AND OVARY IN THREE FAMILIES, Obstetrical & Gynecological Survey, vol.27, issue.3, pp.644-648, 1971.
DOI : 10.1097/00006254-197203000-00014

M. Macdonald, C. Ambrose, M. Duyao, R. Myers, C. Lin et al., A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes, Cell, vol.72, issue.6, pp.971-983, 1993.
DOI : 10.1016/0092-8674(93)90585-E

M. Mahadevan, C. Tsilfidis, L. Sabourin, G. Shutler, C. Amemiya et al., Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene, Science, vol.255, issue.5049, pp.1253-1255, 1992.
DOI : 10.1126/science.1546325

I. Manke, D. Lowery, A. Nguyen, and M. Yaffe, BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting, Science, vol.302, issue.5645, pp.636-639, 2003.
DOI : 10.1126/science.1088877

J. Manley and A. Krainer, A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins), Genes & Development, vol.24, issue.11, pp.1073-1074, 2010.
DOI : 10.1101/gad.1934910

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878644

J. Martinez, C. Baldeyron, and A. Carreira, Molding BRCA2 function through its interacting partners, Cell Cycle, vol.7, issue.21, pp.3389-3395, 2015.
DOI : 10.1093/hmg/dds222

URL : http://www.tandfonline.com/doi/pdf/10.1080/15384101.2015.1093702?needAccess=true

A. Matera and Z. Wang, A day in the life of the spliceosome, Nature Reviews Molecular Cell Biology, vol.36, issue.2, pp.108-121, 2014.
DOI : 10.1016/j.molcel.2009.09.040

N. Mavaddat, S. Peock, D. Frost, S. Ellis, R. Platte et al., Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE, JNCI: Journal of the National Cancer Institute, vol.105, issue.11, pp.812-822, 2013.
DOI : 10.1093/jnci/djt095

A. Mccullough and S. Berget, G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection., Molecular and Cellular Biology, vol.17, issue.8, pp.4562-4571, 1997.
DOI : 10.1128/MCB.17.8.4562

A. Mccullough and S. Berget, An Intronic Splicing Enhancer Binds U1 snRNPs To Enhance Splicing and Select 5' Splice Sites, Molecular and Cellular Biology, vol.20, issue.24, pp.9225-9235, 2000.
DOI : 10.1128/MCB.20.24.9225-9235.2000

T. Mckerrell, N. Park, T. Moreno, C. Grove, H. Ponstingl et al., Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis, Cell Reports, vol.10, issue.8, pp.1239-1245, 2015.
DOI : 10.1016/j.celrep.2015.02.005

A. Meindl, H. Hellebrand, C. Wiek, V. Erven, B. Wappenschmidt et al., Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene, Nature Genetics, vol.668, issue.5, pp.410-414, 2010.
DOI : 10.1016/S0301-472X(02)00782-8

D. Michael and L. Manyuan, Intron--exon structures of eukaryotic model organisms, Nucleic Acids Research, vol.27, issue.15, pp.3219-3228, 1999.
DOI : 10.1093/nar/27.15.3219

Y. Miki, J. Swensen, D. Shattuck-eidens, P. Futreal, K. Harshman et al., A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, vol.266, issue.5182, pp.66-71, 1994.
DOI : 10.1126/science.7545954

G. Millot, M. Carvalho, S. Caputo, M. Vreeswijk, M. Brown et al., variants of uncertain significance, Human Mutation, vol.31, issue.13, pp.1526-1537, 2012.
DOI : 10.1093/nar/gkg595

J. Milner, B. Ponder, L. Hughes-davies, M. Seltmann, and T. Kouzarides, Transcriptional activation functions in BRCA2, Nature, vol.386, issue.6627, pp.772-773, 1997.
DOI : 10.1038/386772a0

S. Minovitsky, S. Gee, S. Schokrpur, I. Dubchak, and J. Conboy, The splicing regulatory element, UGCAUG, is phylogenetically and spatially conserved in introns that flank tissue-specific alternative exons, Nucleic Acids Research, vol.33, issue.2, pp.714-724, 2005.
DOI : 10.1093/nar/gki210

A. Monteiro, A. August, and H. Hanafusa, Evidence for a transcriptional activation function of BRCA1 C-terminal region, Proceedings of the National Academy of Sciences, vol.382, issue.6593, pp.13595-13599, 1996.
DOI : 10.1038/382678a0

D. Mordes, X. Luo, A. Kar, D. Kuo, L. Xu et al., Pre-mRNA splicing and retinitis pigmentosa, Mol Vis, vol.12, pp.1259-1271, 2006.

A. Mortazavi, B. Williams, K. Mccue, L. Schaeffer, and B. Wold, Mapping and quantifying mammalian transcriptomes by RNA-Seq, Nature Methods, vol.14, issue.7, pp.621-628, 2008.
DOI : 10.1128/MCB.14.3.1647

J. Mudge, A. Frankish, J. Fernandez-banet, T. Alioto, T. Derrien et al., The Origins, Evolution, and Functional Potential of Alternative Splicing in Vertebrates, Molecular Biology and Evolution, vol.28, issue.10, pp.2949-2959, 2011.
DOI : 10.1093/molbev/msr127

D. Muller, E. Rouleau, I. Schultz, S. Caputo, C. Lefol et al., An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition, BMC Medical Genetics, vol.75, issue.4, p.121, 2011.
DOI : 10.1086/424388

E. Nagy and L. Maquat, A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance, Trends in Biochemical Sciences, vol.23, issue.6, pp.198-199, 1998.
DOI : 10.1016/S0968-0004(98)01208-0

G. Neidhardt, A. Becker, J. Hauke, J. Horvath, B. Markov et al., The RAD51C exonic splice-site mutations c.404G>C and c.404G>T are associated with familial breast and ovarian cancer, European Journal of Cancer Prevention, vol.26, issue.2, 2016.
DOI : 10.1097/CEJ.0000000000000240

M. Neumann, D. Sampathu, L. Kwong, A. Truax, M. Micsenyi et al., Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis, Science, vol.314, issue.5796, pp.130-133, 2006.
DOI : 10.1126/science.1134108

T. Orban and E. Olah, Emerging roles of BRCA1 alternative splicing, Molecular Pathology, vol.56, issue.4, pp.191-197, 2003.
DOI : 10.1136/mp.56.4.191

A. Osorio, D. Endt, F. Fernández, K. Eirich, M. Hoya et al., Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families, Human Molecular Genetics, vol.21, issue.13, pp.2889-2898, 2012.
DOI : 10.1093/hmg/dds115

T. Ouchi, BRCA1 phosphorylation: Biological consequences, Cancer Biology & Therapy, vol.5, issue.5, pp.470-475, 2006.
DOI : 10.4161/cbt.5.5.2845

R. Padgett, New connections between splicing and human disease, Trends in Genetics, vol.28, issue.4, pp.147-154, 2012.
DOI : 10.1016/j.tig.2012.01.001

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319163

F. Pagani and F. Baralle, Opinion: Genomic variants in exons and introns: identifying the splicing spoilers, Nature Reviews Genetics, vol.74, issue.5, pp.389-396, 2004.
DOI : 10.1093/hmg/9.2.259

F. Pagani, M. Raponi, and F. Baralle, Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution, Proceedings of the National Academy of Sciences, vol.17, issue.5, pp.6368-6372, 2005.
DOI : 10.1016/S0168-9525(01)02281-8

URL : http://www.pnas.org/content/102/18/6368.full.pdf

E. Papaemmanuil, M. Cazzola, J. Boultwood, L. Malcovati, P. Vyas et al., Mutation in Myelodysplasia with Ring Sideroblasts, New England Journal of Medicine, vol.365, issue.15, pp.1384-1395, 2011.
DOI : 10.1056/NEJMoa1103283

D. Park, F. Lesueur, T. Nguyen-dumont, M. Pertesi, F. Odefrey et al., Rare Mutations in XRCC2 Increase the Risk of Breast Cancer, The American Journal of Human Genetics, vol.90, issue.4, pp.734-739, 2012.
DOI : 10.1016/j.ajhg.2012.02.027

A. Patel and J. Steitz, Splicing double: insights from the second spliceosome, Nature Reviews Molecular Cell Biology, vol.4, issue.12, pp.960-970, 2003.
DOI : 10.1038/nrm1259

P. Pharoah, P. Guilford, and C. Caldas, Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families, Gastroenterology, vol.121, issue.6, pp.1348-1353, 2001.
DOI : 10.1053/gast.2001.29611

S. Plon, D. Eccles, D. Easton, W. Foulkes, M. Genuardi et al., Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results, Human Mutation, vol.16, issue.11, pp.1282-1291, 2008.
DOI : 10.1002/humu.20880

T. Popova, E. Manié, G. Rieunier, V. Caux-moncoutier, C. Tirapo et al., Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA1/2 Inactivation, Cancer Research, vol.72, issue.21, pp.5454-5462, 2012.
DOI : 10.1158/0008-5472.CAN-12-1470

C. Pottier, T. Ravenscroft, M. Sanchez-contreras, and R. Rademakers, Genetics of FTLD: overview and what else we can expect from genetic studies, Journal of Neurochemistry, vol.210, pp.32-53, 2016.
DOI : 10.1083/jcb.201502029

U. Pozzoli and M. Sironi, Silencers regulate both constitutive and alternative splicing events in mammals, Cellular and Molecular Life Sciences, vol.62, issue.14, pp.1579-1604, 2005.
DOI : 10.1007/s00018-005-5030-6

R. Prakash, Y. Zhang, W. Feng, and M. Jasin, Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins, Cold Spring Harbor Perspectives in Biology, vol.7, issue.4, p.16600, 2015.
DOI : 10.1101/cshperspect.a016600

O. Puig, A. Gottschalk, P. Fabrizio, and B. Séraphin, Interaction of the U1 snRNP with nonconserved intronic sequences affects 5' splice site selection, Genes & Development, vol.13, issue.5, pp.569-580, 1999.
DOI : 10.1101/gad.13.5.569

V. Quesada, L. Conde, N. Villamor, G. Ordóñez, P. Jares et al., Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia, Nature Genetics, vol.177, issue.1, pp.47-52, 2012.
DOI : 10.2307/2529177

D. Ransburgh, N. Chiba, C. Ishioka, A. Toland, and J. Parvin, Identification of Breast Tumor Mutations in BRCA1 That Abolish Its Function in Homologous DNA Recombination, Cancer Research, vol.70, issue.3, pp.988-995, 2010.
DOI : 10.1158/0008-5472.CAN-09-2850

M. Raponi, A. Douglas, C. Tammaro, D. Wilson, and D. Baralle, Evolutionary Constraint Helps Unmask a Splicing Regulatory Region in BRCA1 Exon 11, PLoS ONE, vol.33, issue.1, p.37255, 2012.
DOI : 10.1371/journal.pone.0037255.s004

J. Rappsilber, U. Ryder, A. Lamond, and M. Mann, Large-Scale Proteomic Analysis of the Human Spliceosome, Genome Research, vol.12, issue.8, pp.1231-1245, 2002.
DOI : 10.1101/gr.473902

M. Reese, F. Eeckman, D. Kulp, and D. Haussler, Improved Splice Site Detection in Genie, Journal of Computational Biology, vol.4, issue.3, pp.311-323, 1997.
DOI : 10.1089/cmb.1997.4.311

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.39.9995

A. Renton, A. Chiò, and B. Traynor, State of play in amyotrophic lateral sclerosis genetics, Nature Neuroscience, vol.67, issue.1, pp.17-23, 2014.
DOI : 10.1002/ana.22611

C. Richards, S. Bale, D. Bellissimo, S. Das, W. Grody et al., Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions, Genet Med Off J Am Coll Med Genet, vol.10, pp.294-300, 2007.

J. Rodríguez and B. Henderson, Identification of a Functional Nuclear Export Sequence in BRCA1, Journal of Biological Chemistry, vol.56, issue.49, pp.38589-38596, 2000.
DOI : 10.1128/MCB.18.12.7288

D. Rossi, A. Bruscaggin, V. Spina, S. Rasi, H. Khiabanian et al., Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness, Blood, vol.118, issue.26, pp.6904-6908, 2011.
DOI : 10.1182/blood-2011-08-373159

R. Roy, J. Chun, and S. Powell, BRCA1 and BRCA2: different roles in a common pathway of genome protection, Nature Reviews Cancer, vol.336, issue.1, pp.68-78, 2012.
DOI : 10.1056/NEJM199705153362003

N. Sakabe, S. Souza, and . De, Sequence features responsible for intron retention in human, BMC Genomics, vol.8, issue.1, p.59, 2007.
DOI : 10.1186/1471-2164-8-59

K. Sathasivam, A. Neueder, T. Gipson, C. Landles, A. Benjamin et al., Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease, Proceedings of the National Academy of Sciences, vol.465, issue.1, pp.2366-2370, 2013.
DOI : 10.1002/cne.10776

K. Savage and D. Harkin, BRCA1, a ???complex??? protein involved in the maintenance of genomic stability, The FEBS Journal, vol.273, issue.4, pp.630-646, 2015.
DOI : 10.1074/jbc.273.40.26061

R. Savkur, A. Philips, and T. Cooper, Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy, Nature Genetics, vol.29, issue.1, pp.40-47, 2001.
DOI : 10.1038/ng704

C. Schneider, C. Will, O. Makarova, E. Makarov, and R. Lührmann, Human U4/U6.U5 and U4atac/U6atac.U5 Tri-snRNPs Exhibit Similar Protein Compositions, U5 and U4atac/U6atac.U5 Tri-snRNPs Exhibit Similar Protein Compositions, pp.3219-3229, 2002.
DOI : 10.1128/MCB.22.10.3219-3229.2002

G. Schnurbein, J. Hauke, B. Wappenschmidt, N. Weber-lassalle, S. Engert et al., RAD51Cdeletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families, Breast Cancer Research, vol.7, issue.6, p.120, 2013.
DOI : 10.1371/journal.pone.0050800

E. Serra, E. Ars, A. Ravella, A. Sánchez, S. Puig et al., Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations, Hum Genet, vol.108, pp.416-429, 2001.

M. Shapiro and P. Senapathy, RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression, Nucleic Acids Research, vol.15, issue.17, pp.7155-7174, 1987.
DOI : 10.1093/nar/15.17.7155

V. Shchepachev, H. Wischnewski, E. Missiaglia, C. Soneson, and C. Azzalin, Mpn1, Mutated in Poikiloderma with Neutropenia Protein 1, Is a Conserved 3???-to-5??? RNA Exonuclease Processing U6 Small Nuclear RNA, Cell Reports, vol.2, issue.4, pp.855-865, 2012.
DOI : 10.1016/j.celrep.2012.08.031

D. Shen and J. Vadgama, BRCA1 and BRCA2 gene mutation analysis: visit to the Breast Cancer Information Core (BIC), Oncol Res, vol.11, pp.63-69, 1999.

H. Shen and M. Green, A Pathway of Sequential Arginine-Serine-Rich Domain-Splicing Signal Interactions during Mammalian Spliceosome Assembly, Molecular Cell, vol.16, issue.3, pp.363-373, 2004.
DOI : 10.1016/j.molcel.2004.10.021

H. Shen and M. Green, RS domain???splicing signal interactions in splicing of U12-type and U2-type introns, Nature Structural & Molecular Biology, vol.13, issue.7, pp.597-603, 2007.
DOI : 10.1093/emboj/16.14.4421

H. Shen, J. Kan, and M. Green, Arginine-Serine-Rich Domains Bound at Splicing Enhancers Contact the Branchpoint to Promote Prespliceosome Assembly, Molecular Cell, vol.13, issue.3, pp.367-376, 2004.
DOI : 10.1016/S1097-2765(04)00025-5

URL : http://doi.org/10.1016/s1097-2765(04)00025-5

S. Shin and I. Verma, BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription, Proceedings of the National Academy of Sciences, vol.10, issue.9, pp.7201-7206, 2003.
DOI : 10.1073/pnas.051624098

R. Singh and T. Cooper, Pre-mRNA splicing in disease and therapeutics, Trends in Molecular Medicine, vol.18, issue.8, pp.472-482, 2012.
DOI : 10.1016/j.molmed.2012.06.006

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411911

E. Smith, An Overview of Hereditary Breast and Ovarian Cancer Syndrome, Journal of Midwifery & Women's Health, vol.353, issue.9, pp.577-584, 2012.
DOI : 10.1056/NEJMp058116

V. Sopik, M. R. Akbari, and S. Narod, mutations: in the clinic and community, Clinical Genetics, vol.112, issue.1, pp.303-312, 2015.
DOI : 10.1016/j.ygyno.2008.10.007

R. Sorek and G. Ast, Intronic Sequences Flanking Alternatively Spliced Exons Are Conserved Between Human and Mouse, Genome Research, vol.13, issue.7, pp.1631-1637, 2003.
DOI : 10.1101/gr.1208803

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC403736

A. Spurdle, F. Couch, F. Hogervorst, P. Radice, and O. Sinilnikova, Prediction and assessment of splicing alterations: implications for clinical testing, Human Mutation, vol.25, issue.Web Server issu, pp.1304-1313, 2008.
DOI : 10.1002/humu.20901

A. Spurdle, S. Healey, A. Devereau, F. Hogervorst, A. Monteiro et al., ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes, Human Mutation, vol.32, issue.1, pp.2-7, 2012.
DOI : 10.1002/humu.21495

J. Staley and C. Guthrie, Mechanical Devices of the Spliceosome: Motors, Clocks, Springs, and Things, Cell, vol.92, issue.3, pp.315-326, 1998.
DOI : 10.1016/S0092-8674(00)80925-3

A. Steffensen, M. Dandanell, L. Jønson, B. Ejlertsen, A. Gerdes et al., Functional characterization of BRCA1 gene variants by mini-gene splicing assay, European Journal of Human Genetics, vol.40, issue.12, pp.1362-1368, 2014.
DOI : 10.1042/BST20120140

T. Sterne-weiler, J. Howard, M. M. Cooper, D. Sanford, and J. , Loss of exon identity is a common mechanism of human inherited disease, Genome Research, vol.21, issue.10, pp.1563-1571, 2011.
DOI : 10.1101/gr.118638.110

T. Sterne-weiler and J. Sanford, Exon identity crisis: disease-causing mutations that disrupt the splicing code, Genome Biology, vol.15, issue.1, p.201, 2014.
DOI : 10.1016/j.bbrc.2004.01.067

URL : http://doi.org/10.1186/gb4150

C. Sugnet, W. Kent, M. Ares, and D. Haussler, TRANSCRIPTOME AND GENOME CONSERVATION OF ALTERNATIVE SPLICING EVENTS IN HUMANS AND MICE, Biocomputing 2004, pp.66-77, 2004.
DOI : 10.1142/9789812704856_0007

S. Sun, S. Ling, J. Qiu, C. Albuquerque, Y. Zhou et al., ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP, Nature Communications, vol.95, p.6171, 2015.
DOI : 10.1073/pnas.95.25.14863

F. Supek, B. Miñana, J. Valcárcel, T. Gabaldón, and B. Lehner, Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers, Cell, vol.156, issue.6, pp.1324-1335, 2014.
DOI : 10.1016/j.cell.2014.01.051

URL : http://doi.org/10.1016/j.cell.2014.01.051

S. Sy, M. Huen, and J. Chen, PALB2 is an integral component of the BRCA complex required for homologous recombination repair, Proceedings of the National Academy of Sciences, vol.252, issue.5009, pp.7155-7160, 2009.
DOI : 10.1126/science.252.5009.1162

Y. Tai, S. Domchek, G. Parmigiani, and S. Chen, Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation Carriers, JNCI Journal of the National Cancer Institute, vol.99, issue.23, pp.1811-1814, 2007.
DOI : 10.1093/jnci/djm203

URL : https://academic.oup.com/jnci/article-pdf/99/23/1811/7688930/djm203.pdf

C. Tammaro, M. Raponi, D. Wilson, and D. Baralle, exon 11 alternative splicing, multiple functions and the association with cancer, Biochemical Society Transactions, vol.3, issue.4, pp.768-772, 2012.
DOI : 10.1073/pnas.0407585101

W. Tarn and J. Steitz, Highly Diverged U4 and U6 Small Nuclear RNAs Required for Splicing Rare AT-AC Introns, Science, vol.273, issue.5283, pp.1824-1832, 1996.
DOI : 10.1126/science.273.5283.1824

S. Tavtigian, G. Byrnes, D. Goldgar, and A. Thomas, Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications, Human Mutation, vol.353, issue.11, pp.1342-1354, 2008.
DOI : 10.1093/oxfordjournals.molbev.a025957

S. Tavtigian, J. Simard, J. Rommens, F. Couch, D. Shattuck-eidens et al., The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds, Nature Genetics, vol.8, issue.3, pp.333-337, 1996.
DOI : 10.1001/jama.273.7.535

M. Telli, K. Timms, J. Reid, B. Hennessy, G. Mills et al., Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer Clin Cancer Res clincanres, 2015.

J. Théry, S. Krieger, P. Gaildrat, F. Révillion, M. Buisine et al., Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes, European Journal of Human Genetics, vol.6, issue.10, pp.1052-1058, 2011.
DOI : 10.1002/humu.9110

B. Thompson, A. Spurdle, J. Plazzer, M. Greenblatt, K. Akagi et al., Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database, Nature Genetics, vol.46, issue.2, pp.107-115, 2014.
DOI : 10.1038/nature11247

T. Thorslund and S. West, BRCA2: a universal recombinase regulator, Oncogene, vol.59, issue.56, pp.7720-7730, 2007.
DOI : 10.1016/S1097-2765(00)80070-2

URL : http://www.nature.com/onc/journal/v26/n56/pdf/1210870a.pdf

J. Turunen, E. Niemelä, B. Verma, and M. Frilander, The significant other: splicing by the minor spliceosome, Wiley Interdisciplinary Reviews: RNA, vol.1, issue.1, pp.61-76, 2013.
DOI : 10.1016/j.celrep.2012.02.001

J. Valcárcel, R. Gaur, R. Singh, and M. Green, Interaction of U2AF65 RS Region with Pre-mRNA Branch Point and Promotion of Base Pairing with U2 snRNA, Science, vol.273, issue.5282, pp.1706-1709, 1996.
DOI : 10.1126/science.273.5282.1706

M. Vallée, D. Sera, T. Nix, D. Paquette, A. Parsons et al., Gene Unclassified Variants, Human Mutation, vol.130, issue.Suppl 1, pp.627-639, 2016.
DOI : 10.1007/s10549-011-1732-7

C. Vance, B. Rogelj, T. Hortobágyi, D. Vos, K. Nishimura et al., Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6, Science, vol.31, issue.23, pp.1208-1211, 2009.
DOI : 10.1146/annurev.neuro.31.061307.090711

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516382

J. Venables, Aberrant and Alternative Splicing in Cancer, Cancer Research, vol.64, issue.21, pp.7647-7654, 2004.
DOI : 10.1158/0008-5472.CAN-04-1910

A. Venkitaraman, Genes to Cancer Pathogenesis and Treatment, Annual Review of Pathology: Mechanisms of Disease, vol.4, issue.1, pp.461-487, 2009.
DOI : 10.1146/annurev.pathol.3.121806.151422

L. Volpi, G. Roversi, E. Colombo, N. Leijsten, D. Concolino et al., Targeted Next-Generation Sequencing Appoints C16orf57 as Clericuzio-Type Poikiloderma with Neutropenia Gene, The American Journal of Human Genetics, vol.86, issue.1, pp.72-76, 2010.
DOI : 10.1016/j.ajhg.2009.11.014

URL : http://doi.org/10.1016/j.ajhg.2009.11.014

M. Wahl, C. Will, and R. Lührmann, The Spliceosome: Design Principles of a Dynamic RNP Machine, Cell, vol.136, issue.4, pp.701-718, 2009.
DOI : 10.1016/j.cell.2009.02.009

L. Walker, P. Whiley, C. Houdayer, T. Hansen, A. Vega et al., Evaluation of a 5-Tier Scheme Proposed for Classification of Sequence Variants Using Bioinformatic and Splicing Assay Data: Inter-Reviewer Variability and Promotion of Minimum Reporting Guidelines, Human Mutation, vol.14, issue.1, pp.1424-1431, 2013.
DOI : 10.1038/sj.onc.1200924

T. Walsh, S. Casadei, K. Coats, E. Swisher, S. Stray et al., Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer, Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer, pp.1379-1388, 2006.
DOI : 10.1001/jama.295.12.1379

C. Wang, K. Chua, W. Seghezzi, E. Lees, O. Gozani et al., Phosphorylation of spliceosomal protein SAP 155??coupled with splicing??catalysis, Genes & Development, vol.12, issue.10, pp.1409-1414, 1998.
DOI : 10.1101/gad.12.10.1409

G. Wang and T. Cooper, Splicing in disease: disruption of the splicing code and the decoding machinery, Nature Reviews Genetics, vol.16, issue.10, pp.749-761, 2007.
DOI : 10.1074/jbc.270.6.2411

J. Wang, P. Smith, A. Krainer, and M. Zhang, Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes, Nucleic Acids Research, vol.33, issue.16, pp.5053-5062, 2005.
DOI : 10.1093/nar/gki810

Z. Wang and C. Burge, Splicing regulation: From a parts list of regulatory elements to an integrated splicing code, RNA, vol.14, issue.5, pp.802-813, 2008.
DOI : 10.1261/rna.876308

Z. Wang, X. X. Van-nostrand, E. Burge, and C. , General and Specific Functions of Exonic Splicing Silencers in Splicing Control, Molecular Cell, vol.23, issue.1, pp.61-70, 2006.
DOI : 10.1016/j.molcel.2006.05.018

A. Ward and T. Cooper, The pathobiology of splicing, The Journal of Pathology, vol.325, pp.152-163, 2010.
DOI : 10.1016/S1525-1578(10)60533-8

K. Wassarman and J. Steitz, The low-abundance U11 and U12 small nuclear ribonucleoproteins (snRNPs) interact to form a two-snRNP complex., Molecular and Cellular Biology, vol.12, issue.3, pp.1276-1285, 1992.
DOI : 10.1128/MCB.12.3.1276

S. West, Molecular views of recombination proteins and their control, Nature Reviews Molecular Cell Biology, vol.4, issue.6, pp.435-445, 2003.
DOI : 10.1038/nrm1127

P. Whiley, M. Hoya, . De-la, M. Thomassen, A. Becker et al., Comparison of mRNA Splicing Assay Protocols across Multiple Laboratories: Recommendations for Best Practice in Standardized Clinical Testing, Clinical Chemistry, vol.60, issue.2, pp.341-352, 2014.
DOI : 10.1373/clinchem.2013.210658

C. Will, C. Schneider, M. Hossbach, H. Urlaub, R. Rauhut et al., The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome, RNA, vol.10, issue.6, pp.929-941, 2004.
DOI : 10.1261/rna.7320604

R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal et al., Identification of the breast cancer susceptibility gene BRCA2, Nature, vol.72, issue.6559, pp.789-792, 1995.
DOI : 10.1038/bjc.1995.493

J. Wu, Y. Li, and R. Jiang, Integrating Multiple Genomic Data to Predict Disease-Causing Nonsynonymous Single Nucleotide Variants in Exome Sequencing Studies, PLoS Genetics, vol.57, issue.3, p.1004237, 2014.
DOI : 10.1371/journal.pgen.1004237.s004

URL : http://doi.org/10.1371/journal.pgen.1004237

W. Wu, A. Koike, T. Takeshita, and T. Ohta, The ubiquitin E3 ligase activity of BRCA1 and its biological functions, Cell Division, vol.3, issue.1, 2008.
DOI : 10.1186/1747-1028-3-1

B. Xia, Q. Sheng, K. Nakanishi, A. Ohashi, J. Wu et al., Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2, Molecular Cell, vol.22, issue.6, pp.719-729, 2006.
DOI : 10.1016/j.molcel.2006.05.022

Y. Xia, G. Pao, H. Chen, I. Verma, and T. Hunter, Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein, Journal of Biological Chemistry, vol.19, issue.7, pp.5255-5263, 2003.
DOI : 10.1016/S0092-8674(00)00126-4

T. Yamazaki, S. Chen, Y. Yu, B. Yan, T. Haertlein et al., FUS-SMN Protein Interactions Link the Motor Neuron Diseases ALS and SMA, Cell Reports, vol.2, issue.4, pp.799-806, 2012.
DOI : 10.1016/j.celrep.2012.08.025

URL : http://doi.org/10.1016/j.celrep.2012.08.025

K. Yano, K. Morotomi, H. Saito, M. Kato, F. Matsuo et al., Nuclear Localization Signals of the BRCA2 Protein, Biochemical and Biophysical Research Communications, vol.270, issue.1, pp.171-175, 2000.
DOI : 10.1006/bbrc.2000.2392

G. Yeo and C. Burge, Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing Signals, Journal of Computational Biology, vol.11, issue.2-3, pp.377-394, 2004.
DOI : 10.1089/1066527041410418

K. Yoshida, M. Sanada, Y. Shiraishi, D. Nowak, Y. Nagata et al., Frequent pathway mutations of splicing machinery in myelodysplasia, Nature, vol.451, issue.7367, pp.64-69, 2011.
DOI : 10.1038/nature06494

X. Yu, C. Chini, M. He, G. Mer, and J. Chen, The BRCT Domain Is a Phospho-Protein Binding Domain, Science, vol.302, issue.5645, pp.639-642, 2003.
DOI : 10.1126/science.1088753

X. Yu, L. Wu, A. Bowcock, A. Aronheim, and R. Baer, with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression, Journal of Biological Chemistry, vol.57, issue.39, pp.25388-25392, 1998.
DOI : 10.1073/pnas.94.11.5820

Y. Yu, C. B. Xia, W. Gangopadhyay, J. Yamazaki, T. Winkelbauer-hurt et al., U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish, Nucleic Acids Research, vol.43, issue.6, pp.3208-3218, 2015.
DOI : 10.1093/nar/gkv157

S. Yuan, S. Lee, G. Chen, M. Song, G. Tomlinson et al., BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo, Cancer Res, vol.59, pp.3547-3551, 1999.

D. Zhang and M. Rosbash, Identification of eight proteins that cross-link to pre-mRNA in the yeast commitment complex, Genes & Development, vol.13, issue.5, pp.581-592, 1999.
DOI : 10.1101/gad.13.5.581

F. Zhang, Q. Fan, K. Ren, and P. Andreassen, PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2, Molecular Cancer Research, vol.7, issue.7, pp.1110-1118, 2009.
DOI : 10.1158/1541-7786.MCR-09-0123

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928587

J. Zhang and S. Powell, The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair, Molecular Cancer Research, vol.3, issue.10, pp.531-539, 2005.
DOI : 10.1158/1541-7786.MCR-05-0192

M. Zhang, Statistical features of human exons and their flanking regions, Human Molecular Genetics, vol.7, issue.5, pp.919-932, 1998.
DOI : 10.1093/hmg/7.5.919

URL : https://academic.oup.com/hmg/article-pdf/7/5/919/2286139/7-5-919.pdf

Z. Zhou and X. Fu, Regulation of splicing by SR proteins and SR protein-specific kinases, Chromosoma, vol.47, issue.3, pp.191-207, 2013.
DOI : 10.1016/j.molcel.2012.05.014

Z. Zhou, L. Licklider, S. Gygi, and R. Reed, Comprehensive proteomic analysis of the human spliceosome, Nature, vol.14, issue.6903, pp.182-185, 2002.
DOI : 10.1016/1044-0305(94)80016-2